Skip to main content Accessibility help
×
Home

Extent of disease at first cancer presentation and previous anxiety and depressive symptoms: the HUNT study

  • Robert Stewart (a1), Sophie Dorothea Fosså (a2), Matthew Hotopf (a3) and Arnstein Mykletun (a4)

Abstract

Background

Depressive symptoms are associated with higher cancer mortality, whereas anxiety symptoms are associated with lower than expected risk.

Aims

This study aimed to investigate the prospective association between depressive/anxiety symptoms and the extent of disease (EOD) of first cancer at diagnosis.

Method

Prospective population-based study conducted from the second wave of the Nord-Trøndelag Health (HUNT) study. Of 65 000 residents comprehensively interviewed and examined for health status, 407 received first lifetime cancer diagnoses 1–3 years later, ascertained from the Cancer Registry of Norway, and had EOD recorded. Patients with localised disease or regional/distant spread at cancer diagnosis were analysed for earlier depressive/anxiety symptoms ascertained by the Hospital Anxiety and Depression Scale in HUNT.

Results

Beyond-local EOD was present in 59.8% of those with neither anxiety nor depression, in 76.6% of those with depression alone (odds ratio, 2.20; 1.08–4.49), in 39.3% of those with anxiety alone (odds ratio, 0.44; 0.20–0.96) and in 57.7% of those with both anxiety and depression (odds ratio, 0.92; 0.41–2.06). After adjustment for demographic and health status, and cancer type, these associations were marginally stronger, but no longer statistically significant (odds ratios, 2.26; 0.84–6.11; 0.43; 0.15–1.26; and 1.00; 0.98–1.03, respectively).

Conclusions

In people who develop cancer, beyond-local EOD at diagnosis was more common in people with previous depression and less common in people with previous anxiety; however, independence from confounding factors could not be concluded.

Copyright

Corresponding author

Correspondence: Arnstein Mykletun, Haukeland University Hospital, Sandviken Hospital, Sandviksleitet 1, 5036 Bergen, Norway. Email: arnstein.mykletun@helse-bergen.no

References

Hide All
1Prince, M, Patel, V, Saxena, S, Maj, M, Maselko, J, Phillips, MR, et al. Global Mental Health 1: no health without mental health. Lancet 2007; 370: 859–77.
2Heila, H, Haukka, J, Suvisaari, J, Lonnqvist, J. Mortality among patients with schizophrenia and reduced hospital care. Psychol Med 2005; 35: 725–32.
3Osby, U, Brandt, L, Correia, N, Ekbom, A, Sparen, P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844–50.
4Mykletun, A, Bjerkeset, O, Dewey, M, Prince, M, Overland, S, Stewart, R. Anxiety, depression and cause-specific mortality. The HUNT study. Psychosom Med 2007; 69: 323–31.
5Chan, CMH, Ahmad, WAW, Yusof, MMD, Ho, GF, Krupat, E. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psychooncology 2015; 24: 718–25.
6Cuijpers, P, Vogelzangs, N, Twisk, J, Kleiboer, A, Li, J, Penninx, BW. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiat 2014; 171: 453–62.
7Ristvedt, SL, Trinkaus, KM. Psychological factors related to delay in consultation for cancer symptoms. Psychooncology 2005; 14: 339–50.
8Ristvedt, SL, Trinkaus, KM. Sex differences in responding to rectal cancer symptoms. Psychol Health 2008; 23: 935–44.
9Burgess, CC, Ramirez, AJ, Smith, P, Richards, MA. Do adverse life events and mood disorders influence delayed presentation of breast cancer? J Psychosomatic Res 2000; 48: 171–5.
10Nosarti, C, Crayford, T, Roberts, JV, Elias, E, McKenzie, K, David, AS. Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer 2000; 82: 742–8.
11Burgess, CC, Potts, HWW, Hamed, H, Bish, AM, Hunter, MS, Richards, MA, et al. Why do older women delay presentation with breast cancer symptoms? Psychooncology 2006; 15: 962–8.
12Robertson, R, Campbell, NC, Smith, S, Donnan, PT, Sullivan, F, Duffy, R, et al. Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer 2004; 90: 1479–85.
13Desai, MM, Bruce, ML, Kasl, SV. The effects of major depression and phobia on stage at diagnosis of breast cancer. Int J Psychiatry Med 1999; 29: 2945.
14Larsen, IK, Småstuen, M, Johannesen, TB, Langmark, F, Parkin, DM, Bray, F, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218–31.
15World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death: Seventh Revision. WHO, 1957.
16Holmen, J, Midthjell, K, Krüger, O, Langhammer, A, Holmen, TL, Bratberg, GH, et al. The Nord-Trøndelag Health Study 1995–97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13: 1932.
17Zigmond, AS, Snaith, RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
18Bjelland, I, Dahl, AA, Haug, TT. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosomatic Res 2002; 52: 6977.
19Roness, A, Mykletun, A, Dahl, AA. Help-seeking behaviour in patients with anxiety disorder and depression. Acta Psych Scand 2005; 111: 51–8.
20Fernando, MS, Ince, PG. MRC Cognitive Function and Ageing Neuropathology Study Group. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 2004; 226: 13–7.
21Oerlemans, ME, van den Akker, M, Schuurman, AG, Kellen, E, Buntinx, F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 2007; 3: 29.
22Prasad, SM, Eggener, SE, Lipsitz, SR, Irwin, MR, Ganz, PA, Hu, JC. Effect of depression on diagnosis, treatment and mortality of men with clinically localized prostate cancer. J Clin Oncol 2014; 32: 2471–8.
23Boyd, CA, Benarroch-Gampel, J, Sheffield, KM, Han, YM, Kuo, YF, Riall, TS. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma. Surgery 2012; 152: 403–13.
24Andersen, BL, Cacioppo, JT, Roberts, DC. Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 1995; 34: 3352.
25Ramirez, AJ, Westcombe, AM, Burgess, CC, Sutton, S, Littlejohns, P, Richards, MA. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999; 353: 1127–31.
26Chang, C-K, Hayes, RD, Broadbent, MTM, Hotopf, M, Davies, E, Møller, H, et al. A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open 2014; 4: e004295.
27Mykletun, A, Bjerkeset, O, Overland, S, Prince, M, Dewey, M, Stewart, R. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry 2009; 195: 118–25.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Extent of disease at first cancer presentation and previous anxiety and depressive symptoms: the HUNT study

  • Robert Stewart (a1), Sophie Dorothea Fosså (a2), Matthew Hotopf (a3) and Arnstein Mykletun (a4)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *